XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2021
May 01, 2020
Accounting Policies [Line Items]              
Prior Period Reclassification Adjustment     $ 5,489 $ 5,241   $ 16,552  
Marketable Securities, Current $ 152,028 $ 152,248       152,248  
Marketable securities, non-current 40,400 50,713       50,713  
Total Marketable Securities 192,428 202,961       202,961  
Unrealized Gain (Loss) on Investments (119) (175)          
Investments, Fair Value Disclosure 192,309 202,786       202,786  
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 13,327       $ (13,495)    
Foreign Currency Transaction Gain (Loss), Realized 9,350       4,075    
Other Nonoperating Gains (Losses) (480)       666    
Total other income (expense), net 22,197       (8,754)    
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments $ 3,288       $ 5,437    
Weighted average shares outstanding — basic 26,072,249       25,945,998    
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/warrants (1) 511,564       0    
Weighted average shares outstanding — diluted 26,583,813       25,945,998    
Weighted average anti-dilutive shares excluded from diluted net income (loss) per share attributable to Cimpress plc (2) 18,447       450,089    
Class of Warrant or Right, Exercise Price of Warrants or Rights             $ 60
Commercial Paper              
Accounting Policies [Line Items]              
Marketable Securities, Current $ 64,478 74,463       74,463  
Unrealized Gain (Loss) on Investments (13) (28)          
Investments, Fair Value Disclosure 64,465 74,435       74,435  
Corporate Debt Securities              
Accounting Policies [Line Items]              
Marketable Securities, Current $ 87,550 77,785       77,785  
Warrant [Member]              
Accounting Policies [Line Items]              
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/warrants (1) 409,561       316,257    
Foreign Exchange Forward [Member]              
Accounting Policies [Line Items]              
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net $ 12,863       $ (13,468)    
Interest Rate Swap [Member]              
Accounting Policies [Line Items]              
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 464       $ (27)    
Marketable securities, current [Member]              
Accounting Policies [Line Items]              
Unrealized Gain (Loss) on Investments (58) (85)          
Investments, Fair Value Disclosure 151,970 152,163       152,163  
Marketable securities, current [Member] | Corporate Debt Securities              
Accounting Policies [Line Items]              
Unrealized Gain (Loss) on Investments (45) (57)          
Investments, Fair Value Disclosure 87,505 77,728       77,728  
Marketable securities, noncurrent [Member]              
Accounting Policies [Line Items]              
Unrealized Gain (Loss) on Investments (61) (90)          
Investments, Fair Value Disclosure $ 40,339 $ 50,623       $ 50,623